All Posts
Common Pitfalls in Stability Study Design and How to Avoid Them
In pharmaceutical development, a stability study is never a mere paperwork exercise. It is the
March 22, 2026
In pharmaceutical development, a stability study is never a mere paperwork exercise. It is the
FOR IMMEDIATE RELEASE DES Pharma to Attend DCAT Week 2026 in New York City Engineering Confidence in
Our latest episode from The DES Pharma podcast explores the rapidly changing trade policy landscape
This guide establishes a clear, phase-appropriate framework for how Analytical Development (AD) and Quality Control
Navigate U.S. tariffs and pharmaceutical supply chains in 2026 — Section 232, IEEPA, USMCA, MFN
Analytical Development vs Process Development: Integrated CMC Strategy Across Drug Development Phases In pharmaceutical and
New York City in March is a study in contrasts. Outside, the weather oscillates between
Engineering Confidence in CMC Development—Let’s Connect in New York City DES Pharma (Dynamic Engineering Solutions)
Schedule a Meeting with DES Pharma at DCAT Week We’re excited to head to New
Developing a therapeutic from lab to commercial launch requires much more than scientific innovation. it
Start building reliable, high-quality drug development programs today.